Please login or register first to view this content.
Urological Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
FDA Approves New Formulation of Ultomiris for PNH and aHUS
Dapagliflozin Gets Breakthrough Therapy Status for CKD Indication
Antidepressant, NSAID Identified as Culprits in SIADH Case
Tenapanor Under Review for Hyperphosphatemia in CKD
FDA Rejects Terlipressin NDA for Hepatorenal Syndrome Type 1
Guideline Updated for Nutrition in Chronic Kidney Disease
FDA Cites Deficiencies in Veverimer NDA for Metabolic Acidosis in CKD
Intravaginal Home-Use Device Cleared for Stress Urinary Incontinence
Ferric Citrate May Improve Iron Parameters Better Than Ferrous Sulfate in CKD
No Cap on Damages in a Medical Battery Case, Says CA Court
Orphan Drug Status Granted to Potential Polycystic Kidney Disease Treatment
Trial Investigating Dapagliflozin in CKD Meets All End Points
Recommendations Updated for Barrier Method Use Among Teens
Finerenone Found to Delay Progression of Diabetic Kidney Disease
FDA Committee Narrowly Votes in Favor of Terlipressin for Hepatorenal Syndrome Type 1
Tolvaptan Lowers Kidney Stone Risk in ADPKD
Adverse Drug Reactions Common in CKD
CDC Updates List of Who Is at Highest Risk for COVID-19
